Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature review
Glioblastoma is not only the most common primary brain tumor, but also the most aggressive. Currently, the most effective treatment of surgery, chemotherapy and radiation therapy allows for a modest median survival of 15 months. Here, we report a case of a 57-year-old male with histologically confir...
Main Authors: | Shahdabul Faraz, Susan Pannullo, Marc Rosenblum, Andrew Smith, A. Gabriella Wernicke |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-11-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834016659791 |
Similar Items
-
Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
by: Menachem Z. Yondorf, et al.
Published: (2020-08-01) -
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
by: O'Day K, et al.
Published: (2013-09-01) -
The Use of Long-Acting Injectable Antipsychotic Therapy for Schizophrenia
by: Jason Jiang, et al.
Published: (2018-09-01) -
Schizophrenia long-acting antipsychotics initiation index (SLAAII)
by: P. Ifteni, et al.
Published: (2021-04-01) -
The place of long-acting injectable antipsychotics in the treatment of schizophrenia
by: John M. Kane, et al.
Published: (2023-03-01)